Radiopharmaceutical – The evolving role of radiation in targeted cancer therapy

Radiopharmaceutical therapy (RPT) offers a unique way to selectively target and destroy cancer cells using radioactive isotopes. The clinical success of therapies like Pluvicto™ and Lutathera^® demonstrate the promise of RPT, particularly in advanced or resistant tumors. Furthermore, preclinical evaluation using appropriate models and imaging platforms plays a pivotal role in ensuring the translational success of these innovative therapies.

As research and technology continue to advance, the field of radiopharmaceuticals holds great potential to revolutionize cancer treatment. Discover why this field is gaining traction, and how by harnessing the power of radiation and precision medicine, RPT offers new hope for more effective cancer therapies.